Skip to main content
Erschienen in: Current Osteoporosis Reports 4/2013

01.12.2013 | Osteoporosis and Cancer (P Taxel, Section Editor)

Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer

verfasst von: Carmen L. Wilson, Kirsten K. Ness

Erschienen in: Current Osteoporosis Reports | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Although substantial increases in survival rates among children diagnosed with cancer have been observed in recent decades, survivors are at risk of developing therapy-related chronic health conditions. Among children and adolescents treated for cancer, acquisition of peak bone mass may be compromised by cancer therapies, nutritional deficiencies, and reduced physical activity. Accordingly, failure to accrue optimal bone mass during childhood may place survivors at increased risk for deficits in bone density and fracture in later life. Current recommendations for the treatment of bone density decrements among cancer survivors include dietary counseling and supplementation to ensure adequate calcium and vitamin D intake. Few strategies exist to prevent or treat bone loss. Moving forward, studies characterizing the trajectory of changes in bone density over time will facilitate the development of interventions and novel therapies aimed at minimizing bone loss among survivors of childhood cancer.
Literatur
1.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. (Eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. (Eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2010/​, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
2.
Zurück zum Zitat •• Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–81. In a large study of childhood cancer survivors who were systematically screened for the presence of chronic health conditions, a high frequency of survivors with endocrine and skeletal conditions were identified. Of note, was the substantial number of conditions that were previously undiagnosed.PubMedCrossRef •• Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–81. In a large study of childhood cancer survivors who were systematically screened for the presence of chronic health conditions, a high frequency of survivors with endocrine and skeletal conditions were identified. Of note, was the substantial number of conditions that were previously undiagnosed.PubMedCrossRef
3.
Zurück zum Zitat Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29.PubMedCrossRef Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29.PubMedCrossRef
4.
Zurück zum Zitat Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26(18):3038–45.PubMedCrossRef Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26(18):3038–45.PubMedCrossRef
5.
Zurück zum Zitat Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr. 1990;117(2 Pt 1):238–44.PubMedCrossRef Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr. 1990;117(2 Pt 1):238–44.PubMedCrossRef
6.
Zurück zum Zitat Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res. 1996;11(11):1774–83.PubMedCrossRef Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res. 1996;11(11):1774–83.PubMedCrossRef
7.
Zurück zum Zitat Henderson RC, Madsen CD, Davis C, et al. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol. 1996;18(4):367–71.PubMedCrossRef Henderson RC, Madsen CD, Davis C, et al. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol. 1996;18(4):367–71.PubMedCrossRef
8.
Zurück zum Zitat Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25(3):580–5.PubMedCrossRef Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25(3):580–5.PubMedCrossRef
9.
Zurück zum Zitat van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002;141(2):204–10.PubMedCrossRef van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002;141(2):204–10.PubMedCrossRef
10.
Zurück zum Zitat Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Therapeut. 2005;27(1):1–11.CrossRef Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Therapeut. 2005;27(1):1–11.CrossRef
11.
Zurück zum Zitat Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int. 2003;14 Suppl 3:S13–8.PubMed Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int. 2003;14 Suppl 3:S13–8.PubMed
12.
Zurück zum Zitat Seeman E. Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology. 2008;47 Suppl 4:iv2–8.PubMedCrossRef Seeman E. Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology. 2008;47 Suppl 4:iv2–8.PubMedCrossRef
13.
Zurück zum Zitat Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11.PubMedCrossRef Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11.PubMedCrossRef
14.
Zurück zum Zitat Nysom K, Holm K, Michaelsen KF, et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol. 1998;16(12):3752–60.PubMed Nysom K, Holm K, Michaelsen KF, et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol. 1998;16(12):3752–60.PubMed
15.
Zurück zum Zitat Arikoski P, Komulainen J, Riikonen P, et al. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res. 1999;14(12):2002–9.PubMedCrossRef Arikoski P, Komulainen J, Riikonen P, et al. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res. 1999;14(12):2002–9.PubMedCrossRef
16.
Zurück zum Zitat Atkinson SA, Halton JM, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl. 1998;11:35–9.PubMedCrossRef Atkinson SA, Halton JM, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl. 1998;11:35–9.PubMedCrossRef
17.
Zurück zum Zitat Warner JT, Evans WD, Webb DK, et al. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res. 1999;45(4 Pt 1):544–51.PubMedCrossRef Warner JT, Evans WD, Webb DK, et al. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res. 1999;45(4 Pt 1):544–51.PubMedCrossRef
18.
Zurück zum Zitat Kadan-Lottick N, Marshall JA, Baron AE, et al. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr. 2001;138(6):898–904.PubMedCrossRef Kadan-Lottick N, Marshall JA, Baron AE, et al. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr. 2001;138(6):898–904.PubMedCrossRef
19.
Zurück zum Zitat Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol. 2004;22(7):1215–21.PubMedCrossRef Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol. 2004;22(7):1215–21.PubMedCrossRef
20.
Zurück zum Zitat van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35(4):415–20.PubMedCrossRef van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35(4):415–20.PubMedCrossRef
21.
Zurück zum Zitat Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20(3):234–40.PubMedCrossRef Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20(3):234–40.PubMedCrossRef
22.
Zurück zum Zitat Brennan BM, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer. 1999;79(11–12):1859–63.PubMedCrossRef Brennan BM, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer. 1999;79(11–12):1859–63.PubMedCrossRef
23.
Zurück zum Zitat Hoorweg-Nijman JJ, Kardos G, Roos JC, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol. 1999;50(2):237–44.CrossRef Hoorweg-Nijman JJ, Kardos G, Roos JC, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol. 1999;50(2):237–44.CrossRef
24.
Zurück zum Zitat Tillmann V, Darlington AS, Eiser C, et al. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res. 2002;17(6):1073–80.PubMedCrossRef Tillmann V, Darlington AS, Eiser C, et al. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res. 2002;17(6):1073–80.PubMedCrossRef
25.
Zurück zum Zitat Al-Tonbary YA, El-Ziny MA, Elsharkawy AA, et al. Bone mineral density in newly diagnosed children with neuroblastoma. Pediatr Blood Cancer. 2011;56(2):202–5.PubMedCrossRef Al-Tonbary YA, El-Ziny MA, Elsharkawy AA, et al. Bone mineral density in newly diagnosed children with neuroblastoma. Pediatr Blood Cancer. 2011;56(2):202–5.PubMedCrossRef
26.
Zurück zum Zitat Sala A, Talsma D, Webber C, et al. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence. European Journal of Cancer Care. 2007;16(4):373–9.PubMedCrossRef Sala A, Talsma D, Webber C, et al. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence. European Journal of Cancer Care. 2007;16(4):373–9.PubMedCrossRef
27.
Zurück zum Zitat Kang MJ, Kim SM, Lee YA, et al. Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors. Osteoporos Int. 2012;23(7):1921–9.PubMedCrossRef Kang MJ, Kim SM, Lee YA, et al. Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors. Osteoporos Int. 2012;23(7):1921–9.PubMedCrossRef
28.
Zurück zum Zitat Holzer G, Krepler P, Koschat MA, et al. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br. 2003;85(2):231–7.PubMedCrossRef Holzer G, Krepler P, Koschat MA, et al. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br. 2003;85(2):231–7.PubMedCrossRef
29.
Zurück zum Zitat • Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian steroid-associated osteoporosis in the pediatric population (stopp) research program. J Bone Miner Res. 2009;24(7):1326–34. In a multicenter cohort study of children newly diagnosed with ALL a high prevalence of vertebral compressions fractures was observed.PubMedCrossRef • Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian steroid-associated osteoporosis in the pediatric population (stopp) research program. J Bone Miner Res. 2009;24(7):1326–34. In a multicenter cohort study of children newly diagnosed with ALL a high prevalence of vertebral compressions fractures was observed.PubMedCrossRef
30.
Zurück zum Zitat Hogler W, Wehl G, van Staa T, et al. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database. Pediatr Blood Cancer. 2007;48(1):21–7.PubMedCrossRef Hogler W, Wehl G, van Staa T, et al. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database. Pediatr Blood Cancer. 2007;48(1):21–7.PubMedCrossRef
31.
Zurück zum Zitat Ismail AA, Cooper C, Felsenberg D, et al. Number and type of vertebral deformities: Epidemiological characteristics and relation to back pain and height loss. European vertebral osteoporosis study group. Osteoporos Int. 1999;9(3):206–13.PubMedCrossRef Ismail AA, Cooper C, Felsenberg D, et al. Number and type of vertebral deformities: Epidemiological characteristics and relation to back pain and height loss. European vertebral osteoporosis study group. Osteoporos Int. 1999;9(3):206–13.PubMedCrossRef
32.
Zurück zum Zitat Kaste SC, Tong X, Hendrick JM, et al. Qct vs dxa in 320 survivors of childhood cancer: Association of BMD with fracture history. Pediatr Blood Cancer. 2006;47(7):936–43.PubMedCrossRef Kaste SC, Tong X, Hendrick JM, et al. Qct vs dxa in 320 survivors of childhood cancer: Association of BMD with fracture history. Pediatr Blood Cancer. 2006;47(7):936–43.PubMedCrossRef
33.
Zurück zum Zitat • Wilson CL, Dilley K, Ness KK, et al. Fractures among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2012;118(23):5920–8. In one of the largest studies to date to examine the occurence of fractures among survivors of childhood cancer, the self-reported prevalence of fracture was found to be similar between childhood cancer survivors and their siblings.PubMedCrossRef • Wilson CL, Dilley K, Ness KK, et al. Fractures among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2012;118(23):5920–8. In one of the largest studies to date to examine the occurence of fractures among survivors of childhood cancer, the self-reported prevalence of fracture was found to be similar between childhood cancer survivors and their siblings.PubMedCrossRef
34.
Zurück zum Zitat Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J. 1998;11(5):1167–77.PubMedCrossRef Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J. 1998;11(5):1167–77.PubMedCrossRef
35.
Zurück zum Zitat Reid IR. Glucocorticoid osteoporosis–mechanisms and management. European Federation of Endocrine Societies. Eur J Endocrinol. 1997;137(3):209–17.PubMedCrossRef Reid IR. Glucocorticoid osteoporosis–mechanisms and management. European Federation of Endocrine Societies. Eur J Endocrinol. 1997;137(3):209–17.PubMedCrossRef
36.
Zurück zum Zitat Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066–72.PubMed Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066–72.PubMed
37.
Zurück zum Zitat Fan C, Foster BK, Wallace WH, et al. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Curr Molec Med. 2011;11(2):140–51.CrossRef Fan C, Foster BK, Wallace WH, et al. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Curr Molec Med. 2011;11(2):140–51.CrossRef
38.
Zurück zum Zitat Meister B, Gassner I, Streif W, et al. Methotrexate osteopathy in infants with tumors of the central nervous system. Med Pediatr Oncol. 1994;23(6):493–6.PubMedCrossRef Meister B, Gassner I, Streif W, et al. Methotrexate osteopathy in infants with tumors of the central nervous system. Med Pediatr Oncol. 1994;23(6):493–6.PubMedCrossRef
39.
Zurück zum Zitat Gnudi S, Butturini L, Ripamonti C, et al. The effects of methotrexate (mtx) on bone. A densitometric study conducted on 59 patients with mtx administered at different doses. Ital J Orthop Traumatol. 1988;14(2):227–31.PubMed Gnudi S, Butturini L, Ripamonti C, et al. The effects of methotrexate (mtx) on bone. A densitometric study conducted on 59 patients with mtx administered at different doses. Ital J Orthop Traumatol. 1988;14(2):227–31.PubMed
40.
Zurück zum Zitat Xian CJ, Cool JC, Scherer MA, et al. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone. 2007;41(5):842–50.PubMedCrossRef Xian CJ, Cool JC, Scherer MA, et al. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone. 2007;41(5):842–50.PubMedCrossRef
41.
Zurück zum Zitat Fan C, Cool JC, Scherer MA, et al. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment. Bone. 2009;44(1):61–70.PubMedCrossRef Fan C, Cool JC, Scherer MA, et al. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment. Bone. 2009;44(1):61–70.PubMedCrossRef
42.
Zurück zum Zitat van Leeuwen BL, Kamps WA, Jansen HW, et al. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev. 2000;26(5):363–76.PubMedCrossRef van Leeuwen BL, Kamps WA, Jansen HW, et al. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev. 2000;26(5):363–76.PubMedCrossRef
43.
Zurück zum Zitat Pastore G, Zurlo MG, Acquaviva A, et al. Health status of young children with cancer following discontinuation of therapy. Med Pediatr Oncol. 1987;15(1):1–6.PubMedCrossRef Pastore G, Zurlo MG, Acquaviva A, et al. Health status of young children with cancer following discontinuation of therapy. Med Pediatr Oncol. 1987;15(1):1–6.PubMedCrossRef
44.
Zurück zum Zitat Bushhouse S, Ramsay NK, Pescovitz OH, et al. Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hematol Oncol. 1989;11(2):134–40.PubMed Bushhouse S, Ramsay NK, Pescovitz OH, et al. Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hematol Oncol. 1989;11(2):134–40.PubMed
45.
Zurück zum Zitat Kalapurakal JA, Thomas PR. Pediatric radiotherapy. An overview. Radiol Clin North Am. 1997;35(6):1265–80.PubMed Kalapurakal JA, Thomas PR. Pediatric radiotherapy. An overview. Radiol Clin North Am. 1997;35(6):1265–80.PubMed
46.
Zurück zum Zitat Fuchs B, Valenzuela RG, Inwards C, et al. Complications in long-term survivors of ewing sarcoma. Cancer. 2003;98(12):2687–92.PubMedCrossRef Fuchs B, Valenzuela RG, Inwards C, et al. Complications in long-term survivors of ewing sarcoma. Cancer. 2003;98(12):2687–92.PubMedCrossRef
47.
Zurück zum Zitat Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60(1):265–74.PubMedCrossRef Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60(1):265–74.PubMedCrossRef
48.
Zurück zum Zitat Wagner LM, Neel MD, Pappo AS, et al. Fractures in pediatric ewing sarcoma. J Pediatr Hematol Oncol. 2001;23(9):568–71.PubMedCrossRef Wagner LM, Neel MD, Pappo AS, et al. Fractures in pediatric ewing sarcoma. J Pediatr Hematol Oncol. 2001;23(9):568–71.PubMedCrossRef
49.
Zurück zum Zitat Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33(4):435–41.PubMedCrossRef Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33(4):435–41.PubMedCrossRef
50.
Zurück zum Zitat Hesseling PB, Hough SF, Nel ED, et al. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl. 1998;11:44–7.PubMedCrossRef Hesseling PB, Hough SF, Nel ED, et al. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl. 1998;11:44–7.PubMedCrossRef
51.
52.
Zurück zum Zitat Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr. 1986;108(2):332.PubMedCrossRef Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr. 1986;108(2):332.PubMedCrossRef
53.
Zurück zum Zitat Brennan BM, Rahim A, Mackie EM, et al. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol. 1998;48(6):777–83.CrossRef Brennan BM, Rahim A, Mackie EM, et al. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol. 1998;48(6):777–83.CrossRef
54.
Zurück zum Zitat Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol. 1999;32(4):272–8.PubMedCrossRef Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol. 1999;32(4):272–8.PubMedCrossRef
55.
Zurück zum Zitat Nussey SS, Hyer SL, Brada M, et al. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl. 1994;399:9–14. discussion: 15.PubMedCrossRef Nussey SS, Hyer SL, Brada M, et al. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl. 1994;399:9–14. discussion: 15.PubMedCrossRef
56.
Zurück zum Zitat Hogler W, Shaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol. 2010;72(3):281–9.CrossRef Hogler W, Shaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol. 2010;72(3):281–9.CrossRef
57.
Zurück zum Zitat Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15(5):728–34.PubMedCrossRef Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15(5):728–34.PubMedCrossRef
58.
Zurück zum Zitat Follin C, Link K, Wiebe T, et al. Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without gh therapy. European Federation of Endocrine Societies. Eur J Endocrinol. 2011;164(5):695–703.PubMedCrossRef Follin C, Link K, Wiebe T, et al. Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without gh therapy. European Federation of Endocrine Societies. Eur J Endocrinol. 2011;164(5):695–703.PubMedCrossRef
59.
Zurück zum Zitat Aisenberg J, Hsieh K, Kalaitzoglou G, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol. 1998;20(3):241–5.PubMedCrossRef Aisenberg J, Hsieh K, Kalaitzoglou G, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol. 1998;20(3):241–5.PubMedCrossRef
60.
Zurück zum Zitat Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol. 1999;33(1):2–8.PubMedCrossRef Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol. 1999;33(1):2–8.PubMedCrossRef
61.
Zurück zum Zitat Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981;304(19):1121–4.PubMedCrossRef Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981;304(19):1121–4.PubMedCrossRef
62.
Zurück zum Zitat Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for hodgkin's disease during childhood or adolescence. Cancer. 1990;65(6):1298–302.PubMedCrossRef Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for hodgkin's disease during childhood or adolescence. Cancer. 1990;65(6):1298–302.PubMedCrossRef
63.
Zurück zum Zitat Papadakis V, Vlachopapadopoulou E, Van Syckle K, et al. Gonadal function in young patients successfully treated for hodgkin disease. Med Pediatr Oncol. 1999;32(5):366–72.PubMedCrossRef Papadakis V, Vlachopapadopoulou E, Van Syckle K, et al. Gonadal function in young patients successfully treated for hodgkin disease. Med Pediatr Oncol. 1999;32(5):366–72.PubMedCrossRef
64.
Zurück zum Zitat Horning SJ, Hoppe RT, Kaplan HS, et al. Female reproductive potential after treatment for hodgkin's disease. N Engl J Med. 1981;304(23):1377–82.PubMedCrossRef Horning SJ, Hoppe RT, Kaplan HS, et al. Female reproductive potential after treatment for hodgkin's disease. N Engl J Med. 1981;304(23):1377–82.PubMedCrossRef
65.
Zurück zum Zitat Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease. J Clin Oncol. 1993;11(1):100–8.PubMed Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease. J Clin Oncol. 1993;11(1):100–8.PubMed
66.
Zurück zum Zitat Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation — a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1997;15(6):2238–46.PubMed Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation — a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1997;15(6):2238–46.PubMed
67.
Zurück zum Zitat Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999;80(5):452–4.PubMedCrossRef Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999;80(5):452–4.PubMedCrossRef
68.
Zurück zum Zitat Sarafoglou K, Boulad F, Gillio A, et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130(2):210–6.PubMedCrossRef Sarafoglou K, Boulad F, Gillio A, et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130(2):210–6.PubMedCrossRef
69.
Zurück zum Zitat Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol. 1989;31(3):363–73.CrossRef Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol. 1989;31(3):363–73.CrossRef
70.
Zurück zum Zitat Howell SJ, Berger G, Adams JE, et al. Bone mineral density in women with cytotoxic-induced ovarian failure. Clin Endocrinol. 1998;49(3):397–402.CrossRef Howell SJ, Berger G, Adams JE, et al. Bone mineral density in women with cytotoxic-induced ovarian failure. Clin Endocrinol. 1998;49(3):397–402.CrossRef
71.
Zurück zum Zitat Critchley HOD, Thomson AB, Wallace WHB. Ovarian and uterine function and reproductive potential. In: Wallace WHB, Green DM, editors. Late effects of childhood cancer. London: Arnold. 2004. Critchley HOD, Thomson AB, Wallace WHB. Ovarian and uterine function and reproductive potential. In: Wallace WHB, Green DM, editors. Late effects of childhood cancer. London: Arnold. 2004.
72.
Zurück zum Zitat Thomson AB, Wallace WHB, Sklar C. Testicular function. In: Wallace WHB, Green DM, editors. Late effects of childhood cancer. London: Arnold. 2004. Thomson AB, Wallace WHB, Sklar C. Testicular function. In: Wallace WHB, Green DM, editors. Late effects of childhood cancer. London: Arnold. 2004.
73.
Zurück zum Zitat Samuda GM, Cheng MY, Yeung CY. Back pain and vertebral compression: an uncommon presentation of childhood acute lymphoblastic leukemia. J Pediatr Orthoped. 1987;7(2):175–8.CrossRef Samuda GM, Cheng MY, Yeung CY. Back pain and vertebral compression: an uncommon presentation of childhood acute lymphoblastic leukemia. J Pediatr Orthoped. 1987;7(2):175–8.CrossRef
74.
Zurück zum Zitat Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998;83(9):3121–9.PubMedCrossRef Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998;83(9):3121–9.PubMedCrossRef
75.
Zurück zum Zitat Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995;126(4):557–64.PubMedCrossRef Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995;126(4):557–64.PubMedCrossRef
76.
Zurück zum Zitat Abrams SA. Normal acquisition and loss of bone mass. Hormone Research. 2003;60 Suppl 3:71–6.PubMedCrossRef Abrams SA. Normal acquisition and loss of bone mass. Hormone Research. 2003;60 Suppl 3:71–6.PubMedCrossRef
77.
Zurück zum Zitat Krishnamoorthy P, Freeman C, Bernstein ML, et al. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Arch Pediatr Adolesc Med. 2004;158(5):491–6.PubMedCrossRef Krishnamoorthy P, Freeman C, Bernstein ML, et al. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Arch Pediatr Adolesc Med. 2004;158(5):491–6.PubMedCrossRef
78.
Zurück zum Zitat Huang TT, Ness KK. Exercise interventions in children with cancer: a review. Int J Pediatr. 2011;2011:461512.PubMed Huang TT, Ness KK. Exercise interventions in children with cancer: a review. Int J Pediatr. 2011;2011:461512.PubMed
79.
Zurück zum Zitat Lanyon LE, Rubin CT. Static vs dynamic loads as an influence on bone remodelling. J Biomechan. 1984;17(12):897–905.CrossRef Lanyon LE, Rubin CT. Static vs dynamic loads as an influence on bone remodelling. J Biomechan. 1984;17(12):897–905.CrossRef
80.
Zurück zum Zitat Odame I, Duckworth J, Talsma D, et al. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer. 2006;46(3):357–62.PubMedCrossRef Odame I, Duckworth J, Talsma D, et al. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer. 2006;46(3):357–62.PubMedCrossRef
81.
Zurück zum Zitat Othman F, Guo CY, Webber C, et al. Osteopenia in survivors of wilms tumor. Int J Oncol. 2002;20(4):827–33.PubMed Othman F, Guo CY, Webber C, et al. Osteopenia in survivors of wilms tumor. Int J Oncol. 2002;20(4):827–33.PubMed
82.
Zurück zum Zitat Zelissen PM, Croughs RJ, van Rijk PP, et al. Effect of glucocorticoid replacement therapy on bone mineral density in patients with addison disease. Ann Intern Med. 1994;120(3):207–10.PubMedCrossRef Zelissen PM, Croughs RJ, van Rijk PP, et al. Effect of glucocorticoid replacement therapy on bone mineral density in patients with addison disease. Ann Intern Med. 1994;120(3):207–10.PubMedCrossRef
83.
Zurück zum Zitat te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, et al. Germline variation in the mthfr and mtrr genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study. Bone. 2011;48(3):571–7.CrossRef te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, et al. Germline variation in the mthfr and mtrr genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study. Bone. 2011;48(3):571–7.CrossRef
84.
Zurück zum Zitat Jones TS, Kaste SC, Liu W, et al. Crhr1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol. 2008;26(18):3031–7.PubMedCrossRef Jones TS, Kaste SC, Liu W, et al. Crhr1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol. 2008;26(18):3031–7.PubMedCrossRef
85.
Zurück zum Zitat Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, Version 3.0. Arcadia, CA: Children's Oncology Group; October 2008; Available on-line:www.survivorshipguidelines.org. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, Version 3.0. Arcadia, CA: Children's Oncology Group; October 2008; Available on-line:www.​survivorshipguid​elines.​org.
86.
Zurück zum Zitat Warady BD, Lindsley CB, Robinson FG, et al. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol. 1994;21(3):530–5.PubMed Warady BD, Lindsley CB, Robinson FG, et al. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol. 1994;21(3):530–5.PubMed
87.
Zurück zum Zitat Saggese G, Bertelloni S, Baroncelli GI, et al. Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis. Am J Dis Child. 1991;145(4):457–62.PubMed Saggese G, Bertelloni S, Baroncelli GI, et al. Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis. Am J Dis Child. 1991;145(4):457–62.PubMed
88.
Zurück zum Zitat Nishi Y, Hamamoto K, Kajiyama M, et al. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta. J Pediatr. 1992;121(3):477–80.PubMedCrossRef Nishi Y, Hamamoto K, Kajiyama M, et al. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta. J Pediatr. 1992;121(3):477–80.PubMedCrossRef
89.
Zurück zum Zitat Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr. 2012;51(11):1011–24.CrossRef Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr. 2012;51(11):1011–24.CrossRef
90.
Zurück zum Zitat Barr RD, Guo CY, Wiernikowski J, et al. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with pamidronate. Med Pediatr Oncol. 2002;39(1):44–6.PubMedCrossRef Barr RD, Guo CY, Wiernikowski J, et al. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with pamidronate. Med Pediatr Oncol. 2002;39(1):44–6.PubMedCrossRef
91.
Zurück zum Zitat Goldbloom EB, Cummings EA, Yhap M. Osteoporosis at presentation of childhood all: management with pamidronate. Pediatr Hematol Oncol. 2005;22(7):543–50.PubMedCrossRef Goldbloom EB, Cummings EA, Yhap M. Osteoporosis at presentation of childhood all: management with pamidronate. Pediatr Hematol Oncol. 2005;22(7):543–50.PubMedCrossRef
92.
Zurück zum Zitat Lee JM, Kim JE, Bae SH, et al. Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Res. 2013;48(2):99–106.PubMedCrossRef Lee JM, Kim JE, Bae SH, et al. Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Res. 2013;48(2):99–106.PubMedCrossRef
93.
Zurück zum Zitat Lethaby C, Wiernikowski J, Sala A, et al. Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. J Pediatr Hematol Oncol. 2007;29(9):613–6.PubMedCrossRef Lethaby C, Wiernikowski J, Sala A, et al. Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. J Pediatr Hematol Oncol. 2007;29(9):613–6.PubMedCrossRef
94.
Zurück zum Zitat • Joyce ED, Nolan VG, Ness KK, et al. Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemia. Arch Phys Med Rehabil. 2011;92(6):873–9. In a study of ALL survivors, muscle strength in the extremities was associated with BMD suggesting a possible role for muscle strengthening interventions as a means of improving bone density among childhood cancer survivors.PubMedCrossRef • Joyce ED, Nolan VG, Ness KK, et al. Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemia. Arch Phys Med Rehabil. 2011;92(6):873–9. In a study of ALL survivors, muscle strength in the extremities was associated with BMD suggesting a possible role for muscle strengthening interventions as a means of improving bone density among childhood cancer survivors.PubMedCrossRef
95.
Zurück zum Zitat Demark-Wahnefried W, Werner C, Clipp EC, et al. Survivors of childhood cancer and their guardians. Cancer. 2005;103(10):2171–80.PubMedCrossRef Demark-Wahnefried W, Werner C, Clipp EC, et al. Survivors of childhood cancer and their guardians. Cancer. 2005;103(10):2171–80.PubMedCrossRef
96.
Zurück zum Zitat Ness KK, Leisenring WM, Huang S, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2009;115(9):1984–94.PubMedCrossRef Ness KK, Leisenring WM, Huang S, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2009;115(9):1984–94.PubMedCrossRef
97.
Zurück zum Zitat Marchese VG, Chiarello LA, Lange BJ. Effects of physical therapy intervention for children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(2):127–33.PubMedCrossRef Marchese VG, Chiarello LA, Lange BJ. Effects of physical therapy intervention for children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(2):127–33.PubMedCrossRef
98.
Zurück zum Zitat San Juan AF, Chamorro-Vina C, Mate-Munoz JL, et al. Functional capacity of children with leukemia. Int J Sports Med. 2008;29(2):163–7.PubMedCrossRef San Juan AF, Chamorro-Vina C, Mate-Munoz JL, et al. Functional capacity of children with leukemia. Int J Sports Med. 2008;29(2):163–7.PubMedCrossRef
99.
Zurück zum Zitat Hartman A, te Winkel ML, van Beek RD, et al. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;53(1):64–71.PubMedCrossRef Hartman A, te Winkel ML, van Beek RD, et al. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009;53(1):64–71.PubMedCrossRef
100.
Zurück zum Zitat Robison LL, Green DM, Hudson M, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104(11 Suppl):2557–64.PubMedCrossRef Robison LL, Green DM, Hudson M, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104(11 Suppl):2557–64.PubMedCrossRef
Metadaten
Titel
Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer
verfasst von
Carmen L. Wilson
Kirsten K. Ness
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current Osteoporosis Reports / Ausgabe 4/2013
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-013-0165-0

Weitere Artikel der Ausgabe 4/2013

Current Osteoporosis Reports 4/2013 Zur Ausgabe

Epidemiology and Pathophysiology (RA Adler, Section Editor)

Osteoporosis and Osteoarthritis, Rheumatoid Arthritis and Spondylarthropathies

Epidemiology and Pathophysiology (RA Adler, Section Editor)

Recent Advances: Osteoporosis in the “Oldest Old”

The Why and How of Fracture Liaison Services (SL Silverman, Section Editor)

Invited Commentary: Fracture Follow-Up Program in an Open Healthcare System

Quality of Care in Osteoporosis (SL Silverman, Section Editor)

Prevention and Treatment of Bone Changes Associated with Exposure to Glucocorticoids

Quality of Care in Osteoporosis (SL Silverman, Section Editor)

Review of New Guidelines for the Management of Glucocorticoid Induced Osteoporosis

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.